Abstract
The detection of α-methylacyl-CoA racemase (AMACR), a novel biomarker for prostate cancer, is demonstrated in serum and urine using a novel immuno-detection method. The detection system consists of a three-electrode conventional electrochemical cell modified with a gating electrode for applying a gating voltage VG to the immune complex immobilized on the working electrode to provide signal amplification. The detection system is realized by integrating gating electrodes with screen-printed electrodes. This detection method does not require involved sample preparation procedures. The detection was demonstrated in serum and urine samples on the nanogram/mL level with VG equal to 0.6V. Detection in serum was also performed on the picogram/mL level with a limit of 100picogram/mL with VG=0.6V being a necessary condition. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
| Original language | English |
|---|---|
| Pages (from-to) | 1441-1444 |
| Number of pages | 4 |
| Journal | Electroanalysis |
| Volume | 26 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jan 1 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarker detection
- Immunoassay
- Prostate cancer biomarker
- Screen printed electrode
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver